CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Daiichi Sankyo Company, Limited - 4568 CFD

4777.72
3.45%
Market Trading Hours* (UTC) Opens on Monday at 01:00

Mon: 01:00 - 02:30 03:30 - 06:00

Tue - Thu: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 34.46
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011022 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011022%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011201 %
Charges from full value of position ($-2.13)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011201%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5%
Stock exchange Japan
Commission on trade 0%

*Information provided by Capital.com

Daiichi Sankyo Co Ltd ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 4948.37
Open* 4869.58
1-Year Change* 3.94%
Day's Range* 4762.86 - 4909.48
52 wk Range 3,566.00-5,162.00
Average Volume (10 days) 5.70M
Average Volume (3 months) 96.16M
Market Cap 8,362.51B
P/E Ratio 55.72
Shares Outstanding 1.92B
Revenue 1,397.02B
EPS 77.08
Dividend (Yield %) 0.8149
Beta 1.07
Next Earnings Date Jan 31, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 4815.72 -110.70 -2.25% 4926.42 4926.42 4814.72
Mar 27, 2024 4948.37 59.05 1.21% 4889.32 4965.14 4862.58
Mar 26, 2024 4867.29 82.69 1.73% 4784.60 4876.67 4779.71
Mar 25, 2024 4805.45 -75.40 -1.54% 4880.85 4901.40 4805.45
Mar 22, 2024 4896.41 41.92 0.86% 4854.49 4956.16 4834.56
Mar 21, 2024 4884.53 -32.72 -0.67% 4917.25 4944.19 4844.65
Mar 19, 2024 4860.41 6.89 0.14% 4853.52 4862.61 4798.76
Mar 18, 2024 4913.45 109.71 2.28% 4803.74 4951.18 4793.77
Mar 15, 2024 4803.45 140.35 3.01% 4663.10 4816.42 4649.14
Mar 14, 2024 4673.98 31.80 0.69% 4642.18 4702.82 4632.09
Mar 13, 2024 4616.95 -137.83 -2.90% 4754.78 4757.66 4600.99
Mar 12, 2024 4756.17 -11.48 -0.24% 4767.65 4775.03 4668.90
Mar 11, 2024 4815.42 46.78 0.98% 4768.64 4816.52 4703.81
Mar 8, 2024 4839.55 -10.97 -0.23% 4850.52 4890.53 4784.69
Mar 7, 2024 4812.43 -130.74 -2.64% 4943.17 4965.13 4776.62
Mar 6, 2024 4924.14 12.89 0.26% 4911.25 4982.09 4876.36
Mar 5, 2024 4931.22 185.53 3.91% 4745.69 4935.22 4713.76
Mar 4, 2024 4891.33 -85.97 -1.73% 4977.30 4984.96 4873.36
Mar 1, 2024 4983.99 66.74 1.36% 4917.25 4986.98 4912.26
Feb 29, 2024 4979.10 46.88 0.95% 4932.22 4990.97 4907.35

Daiichi Sankyo Company, Limited Events

Time (UTC) Country Event
Thursday, April 25, 2024

Time (UTC)

04:00

Country

JP

Event

Full Year 2024 Daiichi Sankyo Co Ltd Earnings Release
Full Year 2024 Daiichi Sankyo Co Ltd Earnings Release

Forecast

-

Previous

-
Tuesday, June 18, 2024

Time (UTC)

01:00

Country

JP

Event

Daiichi Sankyo Co Ltd Annual Shareholders Meeting
Daiichi Sankyo Co Ltd Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 1278480 1044890 962516 981793 929717
Revenue 1278480 1044890 962516 981793 929717
Cost of Revenue, Total 363525 353328 338289 343206 364605
Gross Profit 914953 691564 624227 638587 565112
Total Operating Expense 1159630 970976 894872 842998 845821
Selling/General/Admin. Expenses, Total 471221 358309 333079 302320 277695
Research & Development 341570 260228 227353 197465 203711
Unusual Expense (Income) 1735 -891 -3849 5 -191
Operating Income 118845 73916 67644 138795 83896
Interest Income (Expense), Net Non-Operating 8206 833 1943 2734 3690
Other, Net -197 -1233 4537 -365 -1755
Net Income Before Taxes 126854 73516 74124 141164 85831
Net Income After Taxes 108952 66995 75650 129073 93690
Minority Interest 127 107 -12
Net Income Before Extra. Items 108952 66995 75777 129180 93678
Net Income 109188 66973 75956 129075 93410
Income Available to Common Excl. Extra. Items 108952 66994 75779 129179 93677
Income Available to Common Incl. Extra. Items 109188 66972 75958 129074 93409
Diluted Net Income 109188 66972 75958 129074 93409
Diluted Weighted Average Shares 1918.59 1918.5 1941.97 1947.83 1947.7
Diluted EPS Excluding Extraordinary Items 56.7876 34.92 39.0216 66.3196 48.0961
Dividends per Share - Common Stock Primary Issue 30 27 27 23.3331 23.3331
Diluted Normalized EPS 57.5643 34.4968 37.7333 66.3219 48.0324
Other Operating Expenses, Total -18418 2 2 1
Total Extraordinary Items 236 -22 179 -105 -268
Total Adjustments to Net Income -1 2 -1 -1
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 330202 340479 327480 280317 233925
Revenue 330202 340479 327480 280317 233925
Cost of Revenue, Total 105983 97974 84768 74798 88830
Gross Profit 224219 242505 242712 205519 145095
Total Operating Expense 336753 308929 266282 245935 284672
Selling/General/Admin. Expenses, Total 140406 120955 113486 96373 104736
Research & Development 101155 89760 75723 74931 91107
Other Operating Expenses, Total -10791 240 -7695 -167 -1
Operating Income -6551 31550 61198 34382 -50747
Interest Income (Expense), Net Non-Operating 5954 4635 652 -4966 -1624
Other, Net 1 -1 -1 1
Net Income Before Taxes -596 36185 61849 29415 -52370
Net Income After Taxes 22488 28391 39457 18852 -27345
Minority Interest
Net Income Before Extra. Items 22488 28391 39457 18852 -27345
Net Income 22488 28391 39457 18852 -27345
Total Adjustments to Net Income -1 -1
Income Available to Common Excl. Extra. Items 22488 28391 39457 18851 -27346
Income Available to Common Incl. Extra. Items 22488 28391 39457 18851 -27346
Diluted Net Income 22488 28391 39457 18851 -27346
Diluted Weighted Average Shares 1918.61 1918.61 1918.59 1918.53 1916.76
Diluted EPS Excluding Extraordinary Items 11.721 14.7977 20.5656 9.82575 -14.2668
Dividends per Share - Common Stock Primary Issue 15 0 15 0 13.5
Diluted Normalized EPS 11.721 14.7977 20.5656 9.82575 -14.2668
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 1495050 1345270 1268420 1384120 1393180
Cash and Short Term Investments 607606 778745 671702 673232 560518
Cash & Equivalents 334825 550176 294804 280409 154860
Short Term Investments 272781 228569 376898 392823 405658
Total Receivables, Net 349245 266937 232392 309775 420021
Accounts Receivable - Trade, Net 280681 214576 201032 282540 360377
Total Inventory 301608 217910 200860 173362 176067
Other Current Assets, Total 236592 81679 163466 227750 236578
Total Assets 2508890 2221400 2085180 2105620 2088050
Property/Plant/Equipment, Total - Net 348912 304070 265281 247053 229085
Property/Plant/Equipment, Total - Gross 833666 784994 749961 708607 706579
Accumulated Depreciation, Total -484753 -480924 -484680 -461555 -477495
Goodwill, Net 98330 83555 77706 76760 77851
Intangibles, Net 159609 163884 172822 172499 169472
Long Term Investments 131146 132723 141014 97620 116298
Note Receivable - Long Term 41 181 417 737 797
Other Long Term Assets, Total 275800 191718 159518 126831 101364
Total Current Liabilities 530263 395268 353571 351071 384544
Accounts Payable 80387 68538 68692 70150 73465
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 52325 31088 29678 49879 40422
Other Current Liabilities, Total 397551 295642 255201 231042 270657
Total Liabilities 1063040 870530 813125 799809 838408
Total Long Term Debt 140531 182527 196495 216452 221501
Long Term Debt 101692 143067 163441 183811 220585
Capital Lease Obligations 38839 39460 33054 32641 916
Deferred Income Tax 12647 12444 17516 15641 17166
Minority Interest 464 62
Other Liabilities, Total 379594 280291 245543 216181 215135
Total Equity 1445850 1350870 1272050 1305810 1249640
Common Stock 50000 50000 50000 50000 50000
Additional Paid-In Capital 94494 94633 94633
Retained Earnings (Accumulated Deficit) 1231790 1170210 1277330 1241600 1152810
Treasury Stock - Common -36808 -37482 -261252 -162519 -162964
Other Equity, Total 200874 168146 111479 82096 115168
Total Liabilities & Shareholders’ Equity 2508890 2221400 2085180 2105620 2088050
Total Common Shares Outstanding 1917.34 1916.79 1916.17 1944.22 1943.68
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1523730 1508570 1495050 1437610 1457290
Cash and Short Term Investments 668310 740833 825126 795189 838741
Cash & Equivalents 590768 519664 441921 395176 480219
Short Term Investments 77542 221169 383205 400013 358522
Total Receivables, Net 411772 390517 349111 355358 333495
Accounts Receivable - Trade, Net 411772 390517 349111 355358 333495
Total Inventory 377631 339275 301608 266685 262126
Other Current Assets, Total 66020 37941 19206 20378 22926
Total Assets 2649100 2616070 2508890 2398030 2427780
Property/Plant/Equipment, Total - Net 382653 374152 348912 333670 326171
Goodwill, Net 107462 104849 98330 94973 101957
Intangibles, Net 155766 155681 159609 183064 199136
Long Term Investments 154021 148655 131699 134335 136346
Other Long Term Assets, Total 325466 324166 275288 214379 206877
Total Current Liabilities 532252 551388 530263 457068 428101
Accounts Payable 468149 431384 424036 358379 332224
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 398 41397 52325 41396 41395
Other Current Liabilities, Total 63705 78607 53902 57293 54482
Total Liabilities 1055100 1086200 1063040 983711 960626
Total Long Term Debt 101503 101597 140531 101786 101880
Long Term Debt 101503 101597 101692 101786 101880
Capital Lease Obligations 38839
Deferred Income Tax 13947 13816 12647 16620 18968
Other Liabilities, Total 407397 419400 379594 408237 411677
Total Equity 1594000 1529870 1445850 1414320 1467150
Common Stock 50000 50000 50000 50000 50000
Additional Paid-In Capital 821 55
Retained Earnings (Accumulated Deficit) 1300670 1260320 1231790 1204630 1204960
Treasury Stock - Common -36680 -36800 -36808 -37033 -37187
Other Equity, Total 279187 256353 200874 196727 249326
Total Liabilities & Shareholders’ Equity 2649100 2616070 2508890 2398030 2427780
Total Common Shares Outstanding 1917.45 1917.35 1917.34 1917.16 1917.03
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 126854 73516 74124 141164 85831
Cash From Operating Activities 114514 139226 192207 196601 92033
Cash From Operating Activities 67789 58245 57382 52611 46169
Non-Cash Items 1581 7256 -8893 -4124 5506
Cash Taxes Paid 46248 22580 24525 26181 36146
Cash Interest Paid 2080 1779 1839 2526 1768
Changes in Working Capital -81710 209 69594 6950 -45473
Cash From Investing Activities -257782 212339 -39246 81673 -142520
Capital Expenditures -67366 -76682 -64093 -52565 -66613
Other Investing Cash Flow Items, Total -190416 289021 24847 134238 -75907
Cash From Financing Activities -89594 -86231 -202433 -91637 -66203
Financing Cash Flow Items 0 0 -12908 -9790 -819
Total Cash Dividends Paid -54616 -51730 -48946 -45356 -45339
Issuance (Retirement) of Stock, Net -24 -15 -100190 -85 -45
Issuance (Retirement) of Debt, Net -34954 -34486 -40389 -36406 -20000
Foreign Exchange Effects 12306 16595 5834 -5608 2143
Net Change in Cash -220556 281929 -43638 181029 -114547
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 126854 127450 91265 29415 73516
Cash From Operating Activities 114514 82136 46105 -20764 139226
Cash From Operating Activities 67789 46080 29986 14870 58245
Non-Cash Items 1581 -2373 333 5481 7256
Cash Taxes Paid 46248 32272 19449 9617 22580
Cash Interest Paid 2080 1123 1048 134 1779
Changes in Working Capital -81710 -89021 -75479 -70530 209
Cash From Investing Activities -257782 -275474 -205031 26311 212339
Capital Expenditures -67366 -50595 -33010 -19982 -76682
Other Investing Cash Flow Items, Total -190416 -224879 -172021 46293 289021
Cash From Financing Activities -89594 -85802 -53290 -29658 -86231
Financing Cash Flow Items 0 -1 -2 -2 0
Total Cash Dividends Paid -54616 -54664 -25867 -25911 -51730
Issuance (Retirement) of Stock, Net -24 -19 -12 -6 -15
Issuance (Retirement) of Debt, Net -34954 -31118 -27409 -3739 -34486
Foreign Exchange Effects 12306 11840 29958 19697 16595
Net Change in Cash -220556 -267300 -182258 -4414 281929

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Daiichi Sankyo Company, Limited Company profile

About Daiichi Sankyo Co Ltd

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Daiichi Sankyo Co Ltd revenues increased 10% to Y810.97B. Net income increased 24% to Y94.32B. Revenues reflect Northern America segment increase of 26% to Y179.2B, Europe segment increase of 24% to Y103.97B. Dividend per share remained flat at Y13.50. Basic Earnings per Share excluding Extraordinary Items increased from Y38.99 to Y49.21.

Equity composition

FY'08 1Q&3Q O/S=WAS. 12/07, Name changed from DAIICHI SANKYO CO., LTD. FY'10 Q1 DWAS was estimated. FY'10 Q3 DWAS was estimated. FY'11 Q3 DWAS was estimated.

Industry: Pharmaceuticals (NEC)

第一三共本社ビルa館/B館
日本橋本町3-5-1
CHUO-KU
TOKYO-TO 103-8426
JP

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

US100

18,285.60 Price
+0.020% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,587.18 Price
+1.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

71,324.90 Price
+3.250% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+1.510% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading